ZF2001
id:
zf2001-320-15637757
title:
ZF2001
text:
ZF2001, trade-named Zifivax or ZF-UZ-VAC-2001, is an adjuvanted protein subunit COVID-19 vaccine developed by Anhui Zhifei Longcom in collaboration with the Institute of Microbiology at the Chinese Academy of Sciences. The vaccine candidate is in Phase III trials with 29,000 participants in China, Ecuador, Malaysia, Pakistan, and Uzbekistan. ZF2001 employs technology similar to other protein-based vaccines in Phase III trials from Novavax, Vector Institute, and Medicago. ZF2001 was first approve
brand slug:
wiki
category slug:
encyclopedia
description:
Vaccine against COVID-19
original url:
https://en.wikipedia.org/wiki/ZF2001
date created:
date modified:
2023-12-20T04:54:16Z
main entity:
{"identifier":"Q97154236","url":"https://www.wikidata.org/entity/Q97154236"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/9/94/Coronavirus._SARS-CoV-2.png","width":2048,"height":2048}
fields total:
13
integrity:
15